Back to Trades
Sell4
PTC THERAPEUTICS, INC.
PTCT
Total Value
$335.9K
Net $157.3K sold
Sales
$157.3K
2 transactions
Company Information
- Company Name
- PTC THERAPEUTICS, INC.
- Ticker Symbol
- PTCT
- CIK
- 0001070081
Insider Information
- Role
- Insider
- Location
- WARREN, NJ
Filing Details
- Filing Date
- Apr 8, 2026
- Transaction Date
- Apr 6, 2026
- Accession Number
- 0001578852-26-000012
- Form Type
- 4
- Net Trading Amount
- -$157.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | 2,265 | $39.42 | Exercise | $89.3K |
| Apr 6, 2026 | Common Stock | 822 | $68.91 | Sale | $56.6K |
| Apr 6, 2026 | Common Stock | 1,443 | $69.75 | Sale | $100.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Derivative | 2,265 | $39.42 | Exercise | $89.3K |
Footnotes
- (F1)This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.
- (F2)This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.24 to $69.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F3)This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.30 to $70.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- (F4)This option was granted on January 5, 2023 and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.